{"disease":{"id":"cryptococcal-meningitis","name":"Cryptococcal meningitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":2},"drugs":{"marketed":[{"drug_id":"fluconazole","indication_name":"Cryptococcal meningitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Cryptococcal Meningitis in HIV","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Cryptococcal meningitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"fluconazol","indication_name":"Cryptococcal meningitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluconazol","company_name":"Azienda Sanitaria-Universitaria Integrata di Udine","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02334670","title":"Vietnam Cryptococcal Retention in Care Study Version 1.0","phase":"","overall_status":"UNKNOWN","enrollment_count":2612,"lead_sponsor_name":"National Hospital for Tropical Diseases, Hanoi, Vietnam","has_results":false},{"nct_id":"NCT06666322","title":"Platform Trial For Cryptococcal Meningitis","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03267407","title":"Vietnam Cryptococcal Retention in Care Study - Version 2.1","phase":"","overall_status":"UNKNOWN","enrollment_count":1184,"lead_sponsor_name":"National Hospital for Tropical Diseases, Hanoi, Vietnam","has_results":false},{"nct_id":"NCT00867269","title":"Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia","phase":"","overall_status":"RECRUITING","enrollment_count":950,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00001352","title":"Fungal Infection Susceptibility","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01802385","title":"Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT06178627","title":"Amphotericin B for Non-HIV Cryptococcal Meningitis Patients","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT05685641","title":"Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City","phase":"NA","overall_status":"UNKNOWN","enrollment_count":211,"lead_sponsor_name":"National Institute of Respiratory Diseases, Mexico","has_results":false},{"nct_id":"NCT04031833","title":"Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Matinas BioPharma Nanotechnologies, Inc.","has_results":false},{"nct_id":"NCT00885703","title":"High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04072640","title":"Three Induction Treatments on Cryptococcal Meningitis","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT04296292","title":"The Lived Experience of Participants in an African Randomised Trial","phase":"","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT06414512","title":"Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT04140461","title":"AmB Dose for Cryptococcal Meningitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Shanghai Public Health Clinical Center","has_results":false},{"nct_id":"NCT04532463","title":"Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Pharmacy, Yangon","has_results":false},{"nct_id":"NCT05471063","title":"Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}